CL.CN
Cresco Labs Inc
Price:  
1.58 
CAD
Volume:  
407,700.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CL.CN EV/EBITDA

179.5%
Upside

As of 2025-10-24, the EV/EBITDA ratio of Cresco Labs Inc (CL.CN) is 5.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CL.CN's latest enterprise value is 759.00 mil CAD. CL.CN's TTM EBITDA according to its financial statements is 135.64 mil CAD. Dividing these 2 quantities gives us the above CL.CN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 11.9x - 14.6x 12.8x
Forward P/E multiples 11.1x - 14.8x 11.7x
Fair Price 3.58 - 5.80 4.42
Upside 126.8% - 266.9% 179.5%
1.58 CAD
Stock Price
4.42 CAD
Fair Price

CL.CN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA